🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan · Delayed Price · Currency is JPY
69.00
-9.00 (-11.54%)
Nov 20, 2026, 3:30 PM JST

SymBio Pharmaceuticals Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,0591,3072,4525,58910,0088,257
1,0591,3072,4525,58910,0088,257
Revenue Growth
-30.58%-46.70%-56.13%-44.16%21.21%176.42%
Cost of Revenue
280.813605791,1792,4082,452
Gross Profit
778.139471,8734,4107,6005,804
Selling, General & Admin
-515.822,0912,3712,5843,0823,048
Research & Development
7,2663,2973,3792,6382,5541,736
Other Operating Expenses
-----4.34
Operating Expenses
6,7505,3885,7505,2225,6364,788
Operating Income
-5,972-4,441-3,877-8121,9641,016
Interest Expense
-81.18-149----
Interest & Investment Income
4.3743211-2.7
Currency Exchange Gain (Loss)
21.03-64172117136-20.19
Other Non Operating Income (Expenses)
61.962-17-45-1002.61
EBT Excluding Unusual Items
-5,966-4,648-3,690-7292,0001,001
Gain (Loss) on Sale of Assets
----7--
Asset Writedown
-98.46-109-131-560--
Other Unusual Items
9.178141011060.2
Pretax Income
-6,048-4,749-3,807-1,1952,1061,001
Income Tax Expense
42.842726767927-1,031
Net Income
-6,091-4,776-3,833-1,9621,1792,032
Net Income to Common
-6,091-4,776-3,833-1,9621,1792,032
Net Income Growth
-----41.98%-
Shares Outstanding (Basic)
695045403938
Shares Outstanding (Diluted)
695045404039
Shares Change
44.87%11.34%13.02%0.75%1.97%17.88%
EPS (Basic)
-87.83-95.12-84.99-49.1730.1953.04
EPS (Diluted)
-87.83-95.12-84.99-49.1729.7752.32
EPS Growth
-----43.10%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--4,575-3,435-3981,612114.59
Free Cash Flow Per Share
--91.11-76.17-9.9740.702.95
Gross Margin
73.48%72.46%76.39%78.91%75.94%70.30%
Operating Margin
-563.97%-339.79%-158.12%-14.53%19.62%12.31%
Profit Margin
-575.15%-365.42%-156.32%-35.10%11.78%24.61%
Free Cash Flow Margin
--350.04%-140.09%-7.12%16.11%1.39%
EBITDA
---3,779-7142,0631,110
EBITDA Margin
---154.12%-12.78%20.61%13.44%
D&A For EBITDA
--98989993.96
EBIT
-5,972-4,441-3,877-8121,9641,016
EBIT Margin
---158.12%-14.53%19.62%12.31%
Effective Tax Rate
----44.02%-
Revenue as Reported
-----8,257
Advertising Expenses
-5406929371,4811,643